-
31.发明公开USE OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES AS COLON CANCER CHEMOPREVENTATIVE AND CHEMOTHERAPEUTIC AGENTS 失效用2-羟基-5- phenylazobenzoic衍生物用于预防CHEMO作为活性成分和结肠癌的化疗
公开(公告)号：EP0738152A1
公开(公告)日：1996-10-23
申请号：EP95907293.0
申请日：1995-01-06
CPC分类号： A61K31/655
摘要： The present invention provides a method of colon cancer chemoprevention or chemotherapy comprising administering to an individual suffering from colon cancer or at risk to develop colon cancer a pharmaceutical composition comprising an effective amount of a 2-hydroxy-5-phenylazobenzoic acid derivative or an ester of an active metabolite or an oxidation product of an active metabolite thereof, or a pharmacologically acceptable salt of the 2-hydroxy-5-phenylazobenzoic acid derivative or an ester or an active metabolite or an oxidation product of an active matabolite thereof.
-
公开(公告)号：EP4342465A3
公开(公告)日：2024-06-12
申请号：EP24155114.2
申请日：2009-10-02
发明人： FORBES, William
IPC分类号： A61K31/437 , A61K45/06 , A61K31/08 , A61K31/352 , A61K31/4164 , A61K31/426 , A61K31/4439 , A61K31/606 , A61K31/7016 , A61K31/785 , A61K38/14 , A61K38/31 , A61P1/16 , A61K31/395
CPC分类号： A61K31/08 , A61K31/352 , A61K31/395 , A61K31/4164 , A61K31/426 , A61K31/4439 , A61K31/606 , A61K31/7016 , A61K31/785 , A61K38/14 , A61K38/31 , A61K45/06 , A61K31/437 , A61P1/04 , A61P1/12 , A61P1/16 , A61P1/18 , A61P25/00 , A61P25/28 , A61P31/00 , A61P31/04
摘要： The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.
-
公开(公告)号：EP1996710B1
公开(公告)日：2019-08-14
申请号：EP07752538.4
申请日：2007-03-06
发明人： SAFDI, Alan , TAYLOR, David
IPC分类号： A61K49/00 , A61K9/00 , A61K31/00 , A61K9/02 , A61K45/06 , A61K31/437 , A61K31/21 , A61K31/573
-
公开(公告)号：EP2096912B1
公开(公告)日：2018-05-30
申请号：EP07754015.1
申请日：2007-03-23
发明人： JOHNSON, Lorin
IPC分类号： A61K31/655 , A61P1/00
CPC分类号： A61K31/606 , A61K31/635 , A61K31/655 , A61K31/66 , Y02A50/469
摘要： A method of increasing the bioavailability of 5-aminosalicylate compound by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of 5-aminosalicylate compound in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
-
公开(公告)号：EP3160467A4
公开(公告)日：2018-02-07
申请号：EP15815195
申请日：2015-05-04
发明人： GOLDEN PAM , BORTEY ENOCH , FORBES WILLIAM , PATERSON CRAIG
CPC分类号： A61K31/437 , A61K38/13 , A61K45/06 , A61K2300/00
摘要： The present invention provides new methods and kits for the retreatment of IBS.
-
36.发明公开METHODS OF ADMINISTERING RIFAXIMIN FOR WEIGHT LOSS AND TREATMENT OF OBESITY 审中-公开行政利福昔明的减肥和肥胖症的处理方法
公开(公告)号：EP2894983A4
公开(公告)日：2016-04-13
申请号：EP13836879
申请日：2013-09-13
发明人： RANDALL CHARLES W
CPC分类号： A61K31/437
-
37.发明公开
公开(公告)号：EP2895169A4
公开(公告)日：2016-02-24
申请号：EP13837021
申请日：2013-09-12
发明人： PIMENTEL MARK , CHANG CHRISTOPHER
IPC分类号： A61K31/495
CPC分类号： A61K31/437 , A61K45/06 , A61K2300/00
-
公开(公告)号：EP1737436B8
公开(公告)日：2012-09-26
申请号：EP05754644.2
申请日：2005-05-27
IPC分类号： A61K31/16 , A61K31/655 , A61P1/04
CPC分类号： A61K31/16 , A61K31/655
-
公开(公告)号：EP1737436B1
公开(公告)日：2010-07-07
申请号：EP05754644.2
申请日：2005-05-27
IPC分类号： A61K31/16 , A61K31/655 , A61P1/04
CPC分类号： A61K31/16 , A61K31/655
-
40.发明公开
公开(公告)号：EP2096912A4
公开(公告)日：2010-01-06
申请号：EP07754015
申请日：2007-03-23
发明人： JOHNSON LORIN
IPC分类号： A61K31/655 , A61P1/00
CPC分类号： A61K31/606 , A61K31/635 , A61K31/655 , A61K31/66
摘要： A method of increasing the bioavailability of 5-aminosalicylate compound by administration of an oral dosage form with food is provided, as well as an article of manufacture comprising an oral dosage form of 5-aminosalicylate compound in a suitable container and associated with printed labeling which describes the increased bioavailability of the medication in the container when taken with food.
摘要翻译： 提供了通过向食物施用口服剂型来提高5-氨基水杨酸化合物的生物利用度的方法，以及在合适的容器中包含5-氨基水杨酸酯化合物的口服剂型并与印刷标签相关的制品 描述了当与食物一起服食时，容器中药物的生物利用度增加。
-
-
-
-
-
-
-
-
-
搜索结果
53 条记录 (耗时 0.014 秒)
